Determination of non polar metabolites in human plasma using innovative sample preparation...
Transcript of Determination of non polar metabolites in human plasma using innovative sample preparation...
Determination of non polar metabolites in human plasma using innovative sample preparation strategies coupled with gas chromatography and mass spectrometry
Maria Margarida Gonçalves1, Sandra Sagredo1, Maria Serrano Bernardo1, Benilde Mendes1, Maria Cristina Marques2, Daniel Etlin3, Ana Bragança4 and Valentina Vassilenko4
1Environmental Biotechnology Unit, Faculty of Sciences and Technology, New University of Lisbon, Portugal; 2Faculty of Pharmacy, University of Lisbon, Portugal; 3Unicam Sistemas Analíticos, SA, Portugal; 4Centre of Physics and Technological Research, New University of Lisbon, Portugal
Overview:
The main objective of this work is to develop simple,fast and selective extraction methods to isolate nonpolar metabolites or contaminants from humanplasma.
Solid phase extraction using a novel adsorbant(MonoTrapTM) was tested for direct extration fromdiluted plasma samples or from the correspondingheadspace.
Both direct extraction and headspace extraction withMonoTrapTM revealed the presence of terphenyls andpartially hydrogenated terphenyls in 39 human plasmasamples.
Dispersive liquid-liquid microextraction (DLLME) ofplasma samples was tested using CCl4 or usingheptane. Conventional DLLME procedure was adaptedto allow the use of non halogenated solvents.
A new method of simultaneous derivatisation,extraction and concentration of plasma fatty acids isproposed. This method couples directtransesterification of plasma samples with methanolicKOH and homogeneous liquid-liquid microextraction(HLLME) with halogenated or non halogenatedsolvents. All steps take place in a single vial with anextraction time of 15 min or less.
Introduction:
Metabolomics addresses the screening of compoundswith medium to low molecular weight, with biologicalrelevance as disease or exposure biomarkers [1].
Sample preparation is a key step of the process,because biological fluids are complex samples oftenavailable at limited amounts (1-2 ml in the case ofblood plasma).
The metabolic profile of plasma samples includes freeaminoacids, organic acids, amines, sugar, steroids,nucleic acid bases and other substances [2].
The analysis of these metabolites by GC-MS requiresthe use of appropriated derivatization reactions.
Non polar metabolites like aliphatic hydrocarbons havebeen determined in biological samples (breathsamples) and related to lipid peroxydation processesoccurring in cells of cancer patients or of smokers [3,4].
References
[1] Harin Kanani, Panagiotis K. Chrysanthopoulos, Maria I. Klapa “Standardizing GC–MSmetabolomics” Journal of Chromatography B, 871 (2008) 191–201
[2] Kishore K. Pasikanti, P.C. Ho, E.C.Y. Chan “Gas chromatography/mass spectrometry inmetabolic profiling of biological fluids” Journal of Chromatography B, 871 (2008) 202–211
[3] Leiliane Coelho A. Amorim, Zenilda de L. Cardeal “Breath air analysis and its use as abiomarker in biological monitoring of occupational and environmental exposure to chemicalagents” Journal of Chromatography B, 853 (2007) 1–9
[4] Michael Phillips, Renee N. Cataneo, Andrew R.C. Cummin, Anthony J., Gagliardi, KevinGleeson, Joel Greenberg, Roger A. Maxfield, William N. Rom “Detection of Lung Cancer WithVolatile Markers in the Breath” Chest 123 (2003) 2115-2123
Methods :
Blood samples from 40 volunteers (20 smokers and 20 non smokers) were collected and the corresponding plasmawas isolated and kept at -5ºC until analysis.
Plasma deproteinization was performed adding methanol and separating the precipitates by centrifugation.
Solid phase extraction with MonoTrapTM DSC18 disks (GL Sciences, Japan)
Plasma samples (500L) were diluted with distilled water and extracted with MonoTrapTM DSC18 disks using:
The SPE disks were extracted with dichloromethane, in an ultrasonic bath.
The extract was dried, concentrated to 200 µL and analysed by GC-MS.
.
a) Direct extraction (DE)
MonoTrapTM disks are placed in direct contact with the plasma sample, at 60 ºC, for 1h, under stirring.
b) Headspace extraction (HE)
MonoTrapTM disks suspended in theheadspace over the plasma sample, at60 ºC, for 1h, under stirring.
Homogeneous liquid-liquid microextraction coupled with direct transesterification(HLLME-DT): Plasma samples (500L) were diluted with methanolic KOH; a solutionof organic solvent CCl4 or heptane (50 - 150 µL) in acetone was added to thereaction mixture and an homogeneous solution was obtained. Phase separationwas induced by adding 2 ml of water. After centrifugation the organic phase wasrecovered and injected in a GC-MS-MS (Focus GC, Polaris Q, Thermounicam).
Results : Detection of terphenyls and hydrogenated terphenyls in human plasma SPE with MonoTrap DSC18 disks (DE and HE) + GC-MS
Partially hydrogenated terphenyls are producedin large amounts for industrial use – they areincluded in the HPV (high production volume)chemicals list by US-EPA. They are mainly used asheat transfer fluids and polymer plasticizers.
Extracted Chromatograms with base peak = 230 m/z
DE(Direct Extraction)
HE(Headspace Extraction)
Terphenyls
Diphenylcyclohexanes
Cyclohexylbiphenyls anddiphenylcyclohexanes
RT: 51.79 - 55.33
52.0 52.5 53.0 53.5 54.0 54.5 55.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
RT: 52.89
AA: 308491
RT: 53.31
AA: 95245RT: 54.28
AA: 80384
NL:
8.15E4
Base Peak
m/z=
241.50-
242.50 F:
MS ICIS
MQ8366NF1
RT: 55.17 - 58.72
55.5 56.0 56.5 57.0 57.5 58.0 58.5
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
56.39
56.89
57.87
57.0156.47
57.09 58.0057.7356.26 57.4455.88 58.5355.69 58.3355.29
NL:
2.84E4
Base Peak
m/z=
241.50-
242.50 F:
MS
Soro1-
MonotrapC18-
1
Extracted Chromatograms with base peak = 242 m/z
These compounds have been found in recycledpaper and cardboard, as well as in food productspacked with these recycled materials. Our resultsshow the presence of these contaminants inhuman plasma samples of 39 volunteers, bothsmokers and non smokers.
RT: 51.73 - 61.14
52 53 54 55 56 57 58 59 60 61
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
59.31
60.58
57.72
53.8551.95 58.3356.41 57.54 59.5553.95 58.4352.11 53.10 56.3355.11
NL:
1.06E5
Base Peak
m/z=
235.50-
236.50 F:
MS
Soro1-
MonotrapC18-
1
RT: 53.34 - 57.65
53.5 54.0 54.5 55.0 55.5 56.0 56.5 57.0 57.5
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
RT: 55.53
AA: 5395533
RT: 56.75
AA: 3780512
RT: 54.02
AA: 1045938
RT: 54.54
AA: 161266
RT: 54.26
AA: 72594
NL:
1.39E6
Base Peak
m/z=
235.50-
236.50 F:
MS ICIS
MQ8366NF1
Extracted Chromatograms with base peak = 230 m/z
Dicyclohexylbenzenes
RT: 52.59 - 62.52
53 54 55 56 57 58 59 60 61 62
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
105
Re
lative
Ab
un
da
nce
59.31
60.48
56.53
60.5856.39
53.04
57.7256.89
53.84
57.88
57.00 58.3355.25 60.7460.18 62.0854.58 56.03
NL:
6.01E5
TIC F: MS
Soro1-
MonotrapC
18-1
DE(Direct Extraction)
RT: 52.59 - 61.56
53 54 55 56 57 58 59 60 61
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
RT: 59.31
AA: 2569240
RT: 60.48
AA: 3042690
RT: 56.53
AA: 1709616
RT: 56.39
AA: 1073826RT: 53.04
AA: 959376
RT: 57.72
AA: 438797
RT: 56.89
MA: 408434
RT: 53.84
AA: 460400 RT: 57.88
AA: 258017
RT: 58.33
AA: 41344RT: 55.25
AA: 33574
60.58
57.0060.7460.1854.5853.20 56.03
NL:
6.01E5
TIC F: MS
Soro1-
MonotrapC
18-1
HE(Headspace Extraction)
Results : Extraction of terphenyls and hydrogenated terphenyls using HLLME
Peaknº
NameBase peak area (m/z= 230)
MT-DE MT-HE HLLME
1 o-terphenyl 2429532 241665 1200775
2 m-terphenyl 333761 - 115186
Peaknº
NameBase peak area (m/z= 236)
DE HE HLLME
3 1,2-diphenylcyclohexane 164368 17267 79147
4 1,3-diphenylcyclohexane 1045938 45041 353403
5 1,4-diphenylcyclohexane 72594 5981 61418
6 3-cyclohexylbiphenyl 5395533 457725 2872927
7 4-cyclohexylbiphenyl 3780512 237143 1819588
Peaknº
Name Base peak area (m/z= 242)
DE HE HLLME
8 1,3-dicyclohexylbenzene 308491 117248 231020
9 phenyldicyclohexane 95245 35084 62574
10 1,4-dicyclohexylbenzene 80384 26736 62484
0
1000000
2000000
3000000
4000000
5000000
6000000
1 2 3 4 5 6 7 8 9 10
Pe
ak a
rea
Peak nº
Monotrap - Direct Extraction
Monotrap - Headspace
HLLME
RT: 51.01 - 62.99
52 53 54 55 56 57 58 59 60 61 62
Time (min)
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
59.07
53.76
59.23
60.01
60.38
52.86
57.5253.04
56.20
57.1652.01 57.69 61.5153.99 61.8955.7555.07
NL:
6.52E6
TIC F: MS
dllme_100_
150CCL4_
MQ8365NF
_18_06_02
Base peak 230
Base peak242
Base peak 236
TIC profile from HLLME of a nonsmoker plasma
Results : direct transesterification + HLLME CCl4 or heptane
0
5
10
15
20
25
30
35
40
45
C12:0 C14:0 C16:0 C16:1 C18:0 C18:1 C18:2 C18:3 C20:3 C20:4 C20:5 C22:5 C22:6
Re
lati
ve C
on
cen
trat
ion
(%
pe
ak a
rea)
Fatty Acid
Smoker, CCl4
Smoker, Heptane
Non smoker, CCl4
Non smoker, Heptane
RT: 35.08 - 90.01
40 45 50 55 60 65 70 75 80 85 90
Time (min)
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
59.36
54.04
59.50
64.06 85.15
60.26
64.5569.29
60.59
53.03
69.66 88.6079.5057.7247.02 71.43 79.9665.0849.66 76.3773.8638.15 41.96
NL:
5.42E7
TIC F: MS
dllme_100_
150CCL4_
MQC535F_
23_06_01
Tic profile, FFA methyl estersfrom smoker
plasma
26 Fatty Acid Methyl Esters Identified
(C12:0) Lauric acidC14:0) Myristic acid(C14:0) 12-Methyltetradecanoic acid(C16:1) Palmitoleic acid(C16:0) Palmitic acid(C16:0) 15-methylhexadecanoic acid(C16:0) 14-methylhexadecanoic acid(C17:0), Heptadecanoic acid
( (C20:2)Eicosadienoic acid(C20:1) Eicosenoic acid(C20:0) Eicosanoic acid(C22:6) Docosahexaenoic (2 isomers)(C22:5) Docosapentaenoic(C22:4) Docosatetraenoic
• Fatty acid profile can be obtained with direct transesterification and HLLMEeither with heptane or with CCl4.
• Comparison of 13 reference fatty acid showed no significant differencesbetween smokers and non smokers.
• Although heptane extracts are less concentrated than CCl4 extracts wecould identify 26 fatty acid methyl esters.
(C18:3), Linolenic acid(C18:2), Linoleic acid(C18:1), Oleic acid(C18:1) Elaidic acid(C18:0) Stearic acid(C20:5) Eicosapentaenoic acidC20:4) Eicosatetraenoic acid (3 isomers)(C20:3) Eicosatrienoic acid (2 isomers)
Conclusions :
• Terphenyls and partially hydrogenated terphenyls were extracted from human plasma.
• Extracts of the materials in contact with the plasma samples and blanks of the analytical process revealed no contamination with these compounds.
• SPE of deproteinized and diluted plasma with a new monolithic adsorbant (MonoTrapTM), both in direct contact orfrom the headspace, allows the selective extraction of these plasma contaminants without significant co-extraction ofplasma metabolites. The method with direct contact provides better extraction yield than the headspace extraction.
• To the best of our knowledge this is the first report on the use of non halogenated solvents for any kind of liquid-liquid microextraction. Although showing smaller enrichment factors then halogenated solvents, the non halogenatedsolvents are generally less toxic and therefore can be a environmentally safer alternative.
• When performing DLLME with plasma samples diluted in water the addition of the organic phase (heptane or CCl4), causes the formation of a gel like structure that prevents a good phase separation.
• A new method for the direct derivatization (transesterification) of plasma lipids and simultaneous extraction andconcentration of the corresponding methyl esters was developed. The method uses organic solvents in the microliterrange, is performed in a single vial and has a total derivatization + extraction time of 15 minutes or less.
• The homogeneous liquid-liquid microextraction coupled with direct transesterification allows the fast and sensitivedetermination of up to 40 fatty acid methyl esters derivatives of plasma lipids.
• Terphenyls and partially hydrogenated terphenyls were found, at variable concentrations in 39 out of 40 humanplasma samples analysed.
• No significant differences were found between the smokers and the non smokers group in what concerns fatty acidprofile or aromatic contaminants level.
Aknowledgements: The authors thank Dr. Etsudo Ikeda (GL Sciences, Japan) for the kind offer of MonoTrapTM samples. Thanks are also due to Dr. Carlos Marques (Nova Era Clinical Analysis Laboratory, Lisbon) for supplying the plasma samples.